AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Senate Field Hearing
University of Utah
Salt Lake City UT
June 01 2007; Edited version
One of the FDA's highest priority projects is the Critical Path Initiative. This project has the potential to transform the way medical products in the US are designed, developed, tested and used.
Holding this event at the University of Utah, under the auspices of the Subcommittee and with the cooperation of Senator Bennett, is important symbolically. In today's world of health care and medicine, we are on the brink of unprecedented advances in our ability to predict, diagnose, and treat diseases across the board. But we also face unprecedented challenges in moving those products from the lab to the bedside--and in providing access to those treatments.
That's why it's so important to capitalize on the synergies that are created when public health agencies such as the FDA work closely with stakeholders in academic research community, industry, consumer groups and elsewhere to solve problems that affect us all.